PortfoliosLab logoPortfoliosLab logo
GDOC vs. BBH
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

GDOC vs. BBH - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Goldman Sachs Future Health Care Equity ETF (GDOC) and VanEck Biotech ETF (BBH). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, GDOC achieves a 0.66% return, which is significantly lower than BBH's 7.93% return.


GDOC

1D
-0.22%
1M
-3.14%
6M
0.88%
YTD
0.66%
1Y
15.93%
3Y*
3.79%
5Y*
10Y*
ALL TIME*
-1.65%

BBH

1D
-0.62%
1M
-3.34%
6M
3.63%
YTD
7.93%
1Y
26.29%
3Y*
9.25%
5Y*
-0.78%
10Y*
6.13%
ALL TIME*
10.67%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison


PositionAvg. Volume Value (2W)Avg. Volume Value (1M)Avg. Volume Value (3M)
$1.24M$1.09M$974.35K
$19.39K$11.72K$75.91K

GDOC vs. BBH - Yearly Performance Comparison


2026 (YTD)20252024202320222021
GDOC
Goldman Sachs Future Health Care Equity ETF
0.66%10.74%-1.66%4.60%-17.12%-2.73%
BBH
VanEck Biotech ETF
7.93%21.18%-4.29%3.94%-15.25%0.44%

Correlation

The correlation between GDOC and BBH is 0.81, meaning they have usually moved in the same direction, including during past declines.


Correlation
Correlation (1Y)
Focuses on recent behavior, but can change the most.

0.81

Correlation (3Y)
Balances recent behavior with more history.

0.78

Correlation (All Time)
Calculated using the full available price history since Nov 11, 2021

0.82

The correlation between GDOC and BBH has been stable across timeframes, ranging from 0.78 to 0.82 - a consistent structural relationship.

GDOC vs. BBH - Sectors Allocation Comparison


Sectors
GDOC
BBH

Healthcare

100.0%
100.0%

Consumer Defensive

1.1%

-

Basic Materials

-

-

Communication Services

-

-

Consumer Cyclical

-

-

Energy

-

-

Financial Services

-

-

Industrials

-

-

Real Estate

-

-

Technology

-

-

Utilities

-

-

Healthcare

GDOC
100.0%
BBH
100.0%

Consumer Defensive

GDOC
1.1%
BBH

-

Basic Materials

GDOC

-

BBH

-

Communication Services

GDOC

-

BBH

-

Consumer Cyclical

GDOC

-

BBH

-

Energy

GDOC

-

BBH

-

Financial Services

GDOC

-

BBH

-

Industrials

GDOC

-

BBH

-

Real Estate

GDOC

-

BBH

-

Technology

GDOC

-

BBH

-

Utilities

GDOC

-

BBH

-

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

GDOC vs. BBH — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

GDOC
GDOC Risk / Return Rank: 3333
Overall Rank
GDOC Sharpe Ratio Rank: 3737
Sharpe Ratio Rank
GDOC Sortino Ratio Rank: 4040
Sortino Ratio Rank
GDOC Omega Ratio Rank: 3434
Omega Ratio Rank
GDOC Calmar Ratio Rank: 3030
Calmar Ratio Rank
GDOC Martin Ratio Rank: 2626
Martin Ratio Rank

BBH
BBH Risk / Return Rank: 5656
Overall Rank
BBH Sharpe Ratio Rank: 5454
Sharpe Ratio Rank
BBH Sortino Ratio Rank: 5858
Sortino Ratio Rank
BBH Omega Ratio Rank: 5151
Omega Ratio Rank
BBH Calmar Ratio Rank: 7070
Calmar Ratio Rank
BBH Martin Ratio Rank: 5050
Martin Ratio Rank
The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

GDOC vs. BBH - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Goldman Sachs Future Health Care Equity ETF (GDOC) and VanEck Biotech ETF (BBH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


GDOCBBHDifference
Sharpe ratioReturn per unit of total volatility

-0.36

Sortino ratioReturn per unit of downside risk

-0.45

Omega ratioGain probability vs. loss probability

1.17

1.24

-0.06

Calmar ratioReturn relative to maximum drawdown

1.02

2.50

-1.48

Martin ratioReturn relative to average drawdown

2.21

5.91

-3.70

GDOC vs. BBH - Sharpe Ratio Comparison

The current GDOC Sharpe Ratio is 1.00, which is comparable to the BBH Sharpe Ratio of 1.36. The chart below compares the historical Sharpe Ratios of GDOC and BBH, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

GDOC vs. BBH - Drawdown Comparison

The maximum GDOC drawdown since its inception was -31.01%, smaller than the maximum BBH drawdown of -72.70%. Use the drawdown chart below to compare losses from any high point for GDOC and BBH.


Loading charts...

Drawdown Indicators


GDOCBBHDifference

Max Drawdown

Largest peak-to-trough decline

-31.01%

-72.70%

+41.69%

Max Drawdown (1Y)

Largest decline over 1 year

-15.67%

-10.55%

-5.12%

Max Drawdown (3Y)

Largest decline over 3 years

-22.51%

-22.74%

+0.23%

Max Drawdown (5Y)

Largest decline over 5 years

-39.86%

Max Drawdown (10Y)

Largest decline over 10 years

-39.86%

Current Drawdown

Current decline from peak

-7.82%

-5.22%

-2.60%

Average Drawdown

Average peak-to-trough decline

-15.66%

-20.67%

+5.01%

Ulcer Index

Depth and duration of drawdowns from previous peaks

7.22%

4.46%

+2.76%

Volatility

GDOC vs. BBH - Volatility Comparison

The current volatility for Goldman Sachs Future Health Care Equity ETF (GDOC) is 3.77%, while VanEck Biotech ETF (BBH) has a volatility of 5.31%. This indicates that GDOC experiences smaller price fluctuations and is considered to be less risky than BBH based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


GDOCBBHDifference

Volatility (1M)

Calculated over the trailing 1-month period

3.77%

5.31%

-1.54%

Volatility (6M)

Calculated over the trailing 6-month period

12.46%

14.79%

-2.33%

Volatility (1Y)

Calculated over the trailing 1-year period

16.11%

19.49%

-3.38%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

18.72%

21.53%

-2.81%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

18.72%

22.10%

-3.38%

GDOC vs. BBH - Expense Ratio Comparison

GDOC has a 0.75% expense ratio, which is higher than BBH's 0.35% expense ratio.


Dividends

GDOC vs. BBH - Dividend Comparison

GDOC's dividend yield for the trailing twelve months is around 0.32%, less than BBH's 0.47% yield.


PositionTTM20252024202320222021202020192018201720162015
BBH
VanEck Biotech ETF
0.47%0.51%0.80%0.43%0.47%0.21%0.36%0.34%0.50%0.55%0.30%0.27%
GDOC
Goldman Sachs Future Health Care Equity ETF
0.32%0.32%0.02%0.55%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Frequently Asked Questions


GDOC and BBH have a correlation of 0.81, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

BBH has higher volatility (5.31%) compared to GDOC (3.77%). In terms of maximum drawdown, GDOC dropped -31.01% vs BBH's -72.70%.

On 3-year performance, BBH leads with 9.25% vs 3.79% for GDOC. On fees, BBH is cheaper at 0.35% per year. On volatility, GDOC has been the lower-risk option at 3.77%. The better choice depends on whether you care most about return, fees, risk, or income.

Over the 3-year period, BBH has performed better with a 9.25% return vs 3.79%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

BBH is cheaper with a 0.35% expense ratio, compared with 0.75% for GDOC.

BBH has the higher dividend yield at 0.47%, compared with 0.32% for GDOC.

They also come from different issuers: Goldman Sachs and VanEck. Their fees differ too: 0.75% for GDOC and 0.35% for BBH.

BBH currently has the higher Sharpe Ratio (1.36 vs 1.00), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for GDOC and BBH

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer